{"lastClose": 6.090000152587891, "len": 1069, "date": "2023-01-10", "alpha_1": -0.06026822455095138, "beta_1": 1.6291244963586862, "drawup_1": 1.5486725887776869, "natr_1": 15.063520286493803, "sup_1": -0.5298303263622719, "res_1": 0.03393535393269786, "bullPattern_1": ["ENGULFING"], "bearPattern_1": [], "rsi_1": 24.748037198213588, "adx_1": 73.18928474710684, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.5400840582509805, "stratHoldAlpha_1": 250.6318819524065, "stratHoldDrawdown_1": -0.6256856872316927, "alpha_3mo": -0.9343579870369261, "beta_3mo": 1.6085700050996314, "drawup_3mo": 0.22945207492744557, "natr_3mo": 15.063520286493803, "sup_3mo": -0.3234811523266834, "res_3mo": 0.15927746566302756, "bullPattern_3mo": ["HIKKAKE", "SHORTLINE"], "bearPattern_3mo": [], "rsi_3mo": 42.4908466495471, "adx_3mo": 15.773576628766751, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -3.0558153076790413, "stratHoldAlpha_3mo": 249.25233439637034, "stratHoldDrawdown_3mo": -0.4327327348984953, "Sector": "Health Care", "Country": "United States", "Market Cap": 872471432, "Name": "Allogene Therapeutics Inc.", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2018.0, "alpha%_1": 0.6131827196009314, "beta%_1": 0.8955707162031883, "drawup%_1": 0.9994379679304769, "natr%_1": 0.9999955795733014, "drawdown%_1": 0.08527120388105647, "stratHoldSharpe%_1": 0.26740641633077605, "stratHoldAlpha%_1": 0.12074833528785334, "stratHoldDrawdown%_1": 0.07659612732341087, "alpha%_3mo": 0.06669018989054484, "beta%_3mo": 0.8716377445266932, "drawup%_3mo": 0.4245564923130216, "natr%_3mo": 0.9999947228914897, "drawdown%_3mo": 0.0016295520743238312, "stratHoldSharpe%_3mo": 0.003910789139434933, "stratHoldAlpha%_3mo": 0.0003676091495475917, "stratHoldDrawdown%_3mo": 0.0019275779503369732}